Table 1 Four steps to appropriate genetic assessment in gynaecological oncology for the first routine oncology follow-up visit (3-6 months)
From: Improving attendance to genetic counselling services for gynaecological oncology patients
1. Non-mucinous ovarian, fallopian tube or primary peritoneal cancer | BRCA testing alone or included in a panel | |
2. Histopathology | Mucinous ovarian cancer | MMR IHC |
Endometrioid or clear cell ovarian cancer | MMR IHC | |
Endometrial cancer | MMR IHC | |
3. Family History | Ovarian cancer <50 | Refer to hereditary cancer clinic for further assessment |
Breast cancer <50 | Refer to hereditary cancer clinic for further assessment | |
Endometrial or GIT cancer | MMR IHC | |
4. Post-operative follow up visit | Are investigations completed? Has patient attended hereditary cancer clinic if referred? |